Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
338.1 USD | -0.85% | -2.73% | -6.42% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2024 fiscal year.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.42% | 19.98B | B- | ||
-2.49% | 476B | B- | ||
+10.87% | 95.97B | B- | ||
-23.68% | 42.44B | A- | ||
+2.70% | 41.27B | B- | ||
-27.31% | 2.59B | C+ | ||
-17.77% | 1.35B | B- | ||
+3.06% | 490M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MOH Stock
- Ratings Molina Healthcare, Inc.